diabetes/cases Flashcards
Genetics and DM
- Type 1: 50% btw identical twins
- Type 2: 90% btw identical twins!
HLA association and DM
- Type 1: HLA-DQ/DR
- Type 2: none
Lipids in poorly controlled diabetes/insulin resistance
-HyperTGs with HDL depletion
Obesity and T2DM
- greatest RF
- increased plasma FFAs –> make muscle more insulin resistant
- FFAs increase liver production of glucose
Dx DM
any of the following:
- Two fasting glucoses > 125
- Single glucose >200 with Sx
- Increased glucose lvl on OGT
- HbA1c > 6.5%
Dawn phenomenon
-morning hyperglycemia due to nocturnal HG secretion
Somogyi effect
morning hyperglycemia due to rebound from nocturnal hypoglycemia
Workup morning hyperglycemia in DM
- check 3AM glucose
- if elevated, pt has dawn phenomenon and evening insulin should be increased
- if decreased, pt has Somogyi and evening insulin should be decreased
General Management Diabetes
- Goal HbA1c < 7
- ACEi or ARB if urine + for microalbuminuria (spot >3.5 female, >2.5 male)
- Refer to podiatry if high risk
- Statin if LDL >100
- ACEi or ARB if bp > 130/80
- Aspirin if >30yo
- Pneumococcal vaccine!
Screening in Diabetics
- HbA1c q3mos. Goal 100
- BP every visit. ACE or ARB if >130/80
microalbuminuria
- 30-300mg per 24 hrs
- spot urine Albumin/Cr >3.5 (female), >2.5 (male)
Sx of DM and pathogenesis
- Polyuria: glucose in renal tube is osmotically active
- Polydipsia: reaction to polyuria
- Fatigue: unknown
- Weight loss: anabolic effects of insulin
- Blurred vision: swelling of lens due to osmosis (glucose)
- Fungal infections: Candida likes sugar
- Distal Numbness/tingling. Mononeuropathy: microscopic vasculitis leading to axonal ischemia. Polyneuropathy: multifactorial
Glyburide, Glipizide, Glimepiride (class, MoA, Advantages, SEs)
- Sulfonylureas
- Bind to Katp on pancreas beta-cells, stimulating release of insulin.
- Effective and inexpensive.
- SEs: Hypoglycemia, weight gain
Metformin (MoA, Advantages, SEs)
- enhances glucose uptake (GLUT4) and insulin sensitivity (AMPK)–suppressing beta-ox and liver gluconeogenesis.
- May cause weight loss, does not cause hypoglycemia, reduces cardiac risk (lowers LDL)
- SEs: GI upset, lactic acidosis, metallic taste
- Contraindicated if serum creatinine >1.5!! (risk of lactic acidosis
Acarbose (MoA, Advantages, SEs)
- inhibits brush border alpha-glucosidase and pancreas alpha-amylase, reducing glucose absorption from gut
- Low risk, no significant toxicity
- SEs: GI: cramping, flatulence, diarrhea
Rosiglitazone, pioglitazone (class, MoA, Advantages, SEs)
- Thiazolinediones
- Activate PPARgamma: wide array of actions; decrease insulin resistance, inhibit VEGF, modify adipocyte differentiation, decrease some interleukins, decrease LDL synthesis
- Advantages: reduced insulin level
- SEs: hepatotoxicity (monitor LFTs!)
Exanatide, liraglutide (class, MoA, Advantages, SEs)
- Incretins (GLP-1) mimetics
- Act on pancreas to release insulin in response to meals, prevent glucagon release, promote satiety, reduce liver fat production
Pramlintide
- Amylin mimetic
- aids glucose absorption, slows gastric emptying, promotes satiety, limits glucagon
lispro
Fast onset human insulin – 15 mins onset 4 hr duration
Regular insulin
-30-60 min onset, 4-6hrs duration (only insulin that can be given IV)
NPH insulin/lente
- 2-4 hr onset
- 10-18 hr duration
- most widely used
Ultralente insulin
- long-lasting
- 6-10 hrs onset
- 18-24 hr duration
70/30 insulin
- 70% NPH/30% regular
- onset: 30 min
- duration: 10-16 hr
Glargine (lantus)
- 3-4 hr onset
- 24 hr duration
- given at bedtime
70/30 insulin regimens
- Basic: one pre-breakfast injection (Often 2/3 of total dose), one pre-dinner injection (1/3 total dose)
- supplement with a pre-lunch short-acting if necessary
- adjust doses by fasting/4pm sticks
Intensive insulin regimen
- Ultralente at bedtime
- Regular insulin before each meal adjusted by finger sticks
- shown to decrease incidence of complications
- Serious risk for hypoglycemia
Three-injection insulin regimen
- 70/30 morning
- pre-dinner regular
- pre-bed NPH
T1DM insulin calcuation
- most require .5-1.0 unit/kg per day
- for two-injection regimen, 2/3 in morning, 1/3 in evening
Treatment T2DM
- start w lifestyle
- if fail, start metformin
- if fail, add another agent
- if fail, start insulin
macrovascular complications DM
- mainly, atherosclerosis –> stroke, MI, CHF. Mechanism unknown but proably glycation of lipoproteins, increased PLT adhesion, decreased fibrinolysis
- Silent MIs common
- PVD
- macrovascular complications are what kill ppl. Unclear whether tight control prevents them (as in microvascular)
Diabetic nephropathy
- microvascular complication
- Path: Kimmelstiel-Wilson–hyaline deposition (Xmas balls) pathagnomonic. Can also have diffuse flomerular sclerosis (also in HTN) and isolated GBM thickening
- Microabluminuria/proteinuria. If occurs, must have tight glycemic control and BP control or can progress to ESRD.
- If you catch microalbuminuria early (dipstick is not sensitive enough!), can slow progression w ACEis
Diabetic retinopathy
- microvascular complication
- 75% prevalence after 20 yrs of diabetes. leading cause of blindness inUS
- nonproliferative: hemorrhages, exudates, microaneurysms, venous dilations on funduscopic exam. Usually asymptomatic until macular edema.
- Proliferative: neovascularization and scarring. Vitreal hemorrhage and retinal detachment can occur! Can lead to blindness! Tx w lazer photocoagluation
Diabetic neuropathy
- Peripheral: usually distal/symmetric (“stocking/glove”). Loss of sensation leads to ulcer formation and Charcot joints. Can have painful neuropathy (hypersensitivity to light touch) Tx with gabapentin, TCAs, pregabalin
- CN complications: 2/2 nerve infarctions. Often CNIII, IV, VI.
- Mononeuropathies: 2/2 infaction (media, ulnar, common peroneal) Lumbar plexopathy
- Autonomic neuropathy: impotence, neurogenic bladder, gastroparesis, constipation/diarrhea, postural hypotension
- Tx is complex. NSAIDs, TCAs,, gabapentin may be helpful. Metoclopramide and other promotility agents for gastroparesis
Diabetic third nerve palsy
eye pain, diplopia, ptosis, inability to adduct
-pupils are spared!
Diabetic foot
- Combination of ischemia and neuropathy
- neuropathy can mask PVD (claudication, rest pain)
- increased susceptibility to infection (cellulitis, candidiasis, pneumonia, osteomyelitis, polymicrobial ulcers)
- infected ulcers can –> osteomyelitis –> amputaiton
- Tx: regular foot care!
Screening tests in Diabetes
- A1C
- Spot A-C ratio
- Creatinine/GFR
- B12 if on metformin, esp if neuropathy
- TSH in T1DM, new dyslipidemia, women >50
- fasting lipid profile (q3months if dyslipidemia, q1yr if controlled)
whom to screen for HTN
all adults >18
Dx HTN
-2 elevated measurements >5mins apart. One in each arm. On 2 separate visits
Causes/Frequency of HTN
95-98% = Essential 2-5 = 2ndry
BP cuff reqs
length = 80% arm circumference Width = 40% arm circumference
BMI thresholds
under - 18.5
over - 25
obese: 30-40
Extreme obesity >40
Thiazides +/-s and doses
- Cost effective (HCTZ)
- May cause hyponatremia
- May precipitate gout flares
- May cause urine incontinence in elderly
- Low dose HCTZ (25mg) > 50mg HCTZ or beta blockers
- Start elderly at 6.25 or 12.5 g
Lifestyle mods ranks for HTN
Weight reduction > DASH > dietary Na reduction > physical activity > moderation of EtOH
Labs for someone with new Dx of ET
- EKG (look for LVH, arrhythmias contraindicating BBs/CCBs)
- Urinalysis (proteinuria – HTNive nephropathy, glucosuria)
- Random blood glucose
- Hct (anemia incr strokes, MIs)
- Serum K
- Serum Cr/eGFR
- Serum Ca (May increase BP, nephrolethiasis)
- Fasting lipid profile
- spot ACR is optional
- NOT recommended: Serum NA, TSH, LFTs
Aspirin prophylaxis in HTN
-wait until BP is normal and stable, since aspirin in pt with uncontrolled BP can inc risk of hemorrhage
Tx algorithm HTN
- Lifestyle
- if fail, HCTZ. Titrate to 25 mg (unless compelling reason for another agent)
- if fail, add ACEi, ARB, or CCB
- most ppl require 2+ drugs
BP control worst in
MExican Americans, Native Americans
HTN and African Americans
Severity, impact, prevalence increased
Somewhat reduced response to monotherapy with BBs, ACEis, ARBs compared to diuretics or CCBs
CHD risk EQs
- symptomatic carotid disease
- Peripheral artery disease
- AAA
- Diabetes
- (confers 10 year risk of >20%)
Major CHD RFs
- cigarette smoking
- HTN
- Low HDL (60 is negative risk factor
- FHx premature CHD (male 45, women >55
Almost everyone with 0-1 RF has a <10% 10 year risk
Statin Rx algorythm
- CHD or CHD Risk Eq (10 yr risk >20%) –> TLC at 100, Statin at 130
- 2+ RFs (10 yr risk TLC at 130, Statin at 130 if 10yr risk is 10-20%
- 0-1 RFs (10 yr risk TLC at 160, Statin at 190 (optional 160-190)
Resistant HTN
- Fails to improve on appropriate doses of 3 drugs, including a diuretic
- Causes: Excess Na, Inadequate diuresis, NSAIDs, OTCs, etc, excess EtOH, 2ndry HTN
Kleinman’s Questions
- What do you think caused your problem? What do you call it?
- Why do you think it started when it did
- How does it affect your life?
- How severe is it? What worries you the most?
- What kind of treatment do you think will work?
- How can the doctor be most helpful to you?
- What is most important to you?
- Have you seen anyone else about this problem?
- Have you used non-medical remedies?
- Who advises you about your health?
PE findings COPD
- Increased AP diameter
- Decreased diaphragmatic excursion
- Wheezing (often end-expiratory)
- Prolonged expiratory phase
PE findings CHF
- inspiratory crackles/dullness to percussion (edema)
- S3
- PMI displaced laterally
- Peripheral edema
- Increased JVD
- Hepatojugular reflux
CXR in pts with dyspnea
not helpful to rule in/out COPD, but to look for other causes (14% of CXRs)
COPD on spirometry
FEV1/FVC 80% = mild
50-79% = moderate
30-49% = Severe
<30% = Very Severe
Adverse effects of Beta-agonist overuse
tachycardia
somatic tremor
hypokalemia (especially with thiazide)
Tx Moderate COPD
- (FEV1 50-80% predicted)
- inhaled anticholinergics alone or in combination with SABA
Tx Severe COPD
(FEV1 <50% predicted)
-add inhaled glucocorticoids to anticholinergics (best with LABA)
Tetanus vaccine schedule
-Td (can be TdaP) q10 after initial TdaP
COPD exacerbation
-acute change in baseline dyspnea, cough, and/or sputum.
-most commonly infection/air pollution
-Tx: inhaled bronchodilators.
Abx if: inc dyspnea, sputum, and sputum purulence, or req’s MV
COPD and CHF
- major complication
- chronic hypoxia –> pulm vascoconstriction –> pulm HTN –> muscularization, intimal hyperplasia, fibrosis, obliteration –> Cor Pulmonale –> edema/death
PMH for obesity
Screen for:
-Cushing’s (easy bruising, hyperpigmentation, muscle weakness)
-Hypothyroid (fatigue, cold intolerance, constipation)
-Hypogonadism (decreased libido)
-Sleep Apnea
CVD (chest pain/pressure, dyspnea
Cerebro (changes in vision or focal neuro Sx)
-PVD: claudication
Obesity and cancer
-BMI >40 –> increased death from NHL, MM, GI cancers, kidney, prostate, breast, uterus, cervix, ovary
Metabolic Syndrome
3/5 of:
-fasting glucose > 100
-BP > 130/85
TGs >150
HDL <50 (women)
-Abdominal obesity
5 As of behavioral counseling
- Assess practices/risk factors
- Advise change
- Agree on goals
- Assist in change/motivational barriers
- Arrange follow-up/support/referral
Estimated Daily Caloric Requirement
Basal metabolic rate + activity-dependent needs
BMR = weight in lbs * 10
Activity-dependent needs = weight in lbs * F
F = 1.3 if sedentary
- 5 for moderate activity
- 7 for heavy activity
- 9 for intense activity
Reasonable weight loss goals (long and short term)
Reasonable long-term goal: A modest 5% to 10% reduction in body weight can produce significant benefits in health outcomes.
Reasonable short-term goal: Losing half a pound to a pound a week.
Pharm Tx obesity
- Orlistat: GI lipase inhibitor which decreases fat absorption, Side effects include gastrointestinal discomfort, fecal incontinence, and malabsorption of fat-soluble vitamins. Orlistat has been shown to result in modest (3-5 kg) weight loss when used in conjunction with calorie restriction and physical activity.
- Phenetermine: stimulant/appetite suppressant. Side effects include tachycardia, hypertension, restlessness, insomnia, and tremor. Because of the potential for addiction and withdrawal, phentermine is indicated only for short-term use.
indications for bariatric surgery
- BMI >40 or
- BMI >35 with severe health complications
Differentiating HF vs non-cardiac causes of dyspnea
Normal BNP effectively rules out CHF
Diastolic HF
- Sx of HF w/ preserved EF
- impaired LV filling
- more common in older women
Tx class II CHF
- ACEi – reduce mortality in systolic HF
- ARBs – improve mortality in systolic HF
- Digoxin – improves Sx and hospitalizations. Be careful in renal insufficiency pts
- Loop diuretics – central role. Caution in diastolic failure (worsen filling)
- BBs – central role in reducing mortality but can worsen HF initially. Don’t use in decompensated HF. titrate slowly.
- Eplerenone – improves mortality/hospitalization in Class II HF
Typical/Atypical agina chest pain
- Substernal
- Precipitated by exertion
- Relief w/i 10mins rest or with nitroglycerin
Typical angina : all 3 present
Atypical angina: 2 present
Nonanginal: 0-1
evaluation of suspected CHF
- ETT: can be good for intermediate risk pts, but negative test doesn’t r/o CHF. Can’t use in people with baseline complicated EKGs
- Stress echo/Nuclear stress testing: more sensitive. Can jump to these in new-onset CHF
management of diastolic HF
- less well studied than systolic HF
- minimize fluid overload w diuretics (careful not to over-do…low preload can worsen ventricular filling.
- slow down HR (esp in Afib)
- Manage comorbid CHD
- Often start on BB and non-DHP CCB (minimize cardiac O2 demand with less reflex tachycardia than DHPs)
FHx Breast Cancer risk
-increased risk if first-degree relative had it
Breast Cancer screening
- Self exams: no evidence of reduced mortality
- Clinical exams: q3 for women in 20s-30s, q1 with mammogram 40+ (ACS) …
- USPSTF: q2 for 50-74
Cervical Cancer screening
- 21-29: q3
- 30-65: q3, or q5 if HPV testing also
- 65+: may stop if 3 consecutive normal paps or 2 consecutive normal with HPV-
Cervical cancer RFs
- early onset sex
- multiple lifetime partners
- Cigarettes
- Immunosuppression
screening for endometrial/ovarian cancer
none if asymptomatic
evaluation breast lump
- precise Hx, nipple d/c? change (esp w cycle)
- Exam. U/S can help determine if cystic
- If solid –> mammography
- If cystic –> FNA
RFs breast cancer
- FHx
- Prolonged exposure to estrogen (early menarche, late menopause, low parity)
- Genetic (BRCA1/2)
- Sex/Age
- increased breast density
- high alcohol intake
- Obesity
menopause definition age, normal Sx, and worrisome Sx
- No menstruations for 12 months
- average age = 51. Smoking hastens onset
- normal Sx: hotflashes/vasomotor Sx, atrophic vaginitis (dyness and dyspareunia)
- worrisome Sx: heavy bleeding, very tightly spaced menses, bleeding >7days
Calcium supplementation in women
- premenopausal: 1000mg/day
- postmenopausal: 1500 mg/day
- USPSTF currently recommends against supplementation. Try to increase through dairy and do weight bearing exercise
Osteoporosis screening
- women >65: DEXA scan
- women 9% risk over 10 years
RFs osteoporosis
- early menopause,
- sedentary
- white
- Hx of fracture
- cigarette
- Obesity is NEGATIVE RF
Gardasil
- 6, 11 (warts)
- 16/18 (most cervical cancers)
- females 9-26
- 3 doses
- before, shortly after sexual debut
Cervarix
-16/18 (most cervical cancers)
-31/45
-females 10-25
-3 doses
before sexual debut or shortly after
“Three C’s of addiction”
Compulsion to use
lack of Control
Continued use despite consequences
Stages of Behavior change
PRe-contemplative
Contemplative
Active
Relapse
Oral medications to aid in smoking cessation
- Buproprion (often first line), Varenicline
- somewhat effective: 1.5-3x at 12 months
- most effective in group setting and with series of counseling sessions
PE signs dyslipidemia
corneal arcus, xanthelesma, acanthosis nigricans
PE signs atherosclerosis
Decreased peripheral pulses, carotid bruits
Colon cancer screening options
- Screening colonoscopy q10
- three stools for blood q1 and flex sig q5
- FOBT q1
- CT colography is experimental
Exercise stress test in asymptomatic pts
-may be useful in men >45 with 1+ RF
EKG changes suggesting CAD
- Horizontal ST depression/downsloping ST segment –>cardiac ischemia
- Convex ST elevation –> acute MI
- Q waves >25% of R wave and >.04s –> infarction
chlamydia screening
- Grade A: all sexually active non-regnant women 25 at increased risk
- Grade B: All pregnant women 25 at increased risk
- Grade I: men
Folic acid supplementation
- All women planning or capable of pregnancy: 400-800mcg daily
- 1 mg in diabetes/epilepsy. 4 mg in pts w h/o pregnancy w NT defect
HTN and pregnancy
- avoid ACEis, ARBs, thiazides
- optimize control.
- 1mg folate daily
Warfarin and pregnancy
switch to heparin
Vitamins and pregnancy
avoid overuse of A or D
Goodell’s sign
softening of cervix in pregnancy
Hegar’s sign
softening of uterus in pregnancy
Chadwick’s sign
bluish-purple hue in cervix/vaginal walls caused by hyperemia
Estimated gestational Age vs Actual Embryonic Age
- EGA = LNMP
- actual embryonic age : EGA - 2 weeks
Calculating expected due date
-LMNP
+ 1 year
-3 months
+1 week
Lx in pregnancy
- CBC
- Rubella (if non-immune, need to be vaccinated postpartum (live vaccine))
- HBsAg (major risk
- Type (RH(D)-negative women should receive anti(D)IG (RhoGAM) to prevent hemolytic disease of newborn)
- RPR
- HIV
serum hCG vs urine
- urine specific but not sensitive in early pregnancy
- if high index of suspicion, do serum when urine is negative
bleeding and miscarriage
- 1/4 pregnant patients experience vaginal bleeding in the first trimester
- when there is significant bleeding in the first trimester, there is 25-50% chance of miscarriage
Ectropion
- Central part of cervix appears red from mucous-producing endocervical epithelium protruding thorugh the os.
- no significance, more common in women taking OCPs
Lx in suspected miscarriage
- Progesterone: if >25, strongly suggests viable intrauterine pregnancy. If <5, strongly suggests evolving miscarriage or ectopic. If 5-25, inconclusive
- quant bHCG: definitive when combined with U/S
U/S and EGA/EDD
in first and second trimester, if >7 days from EGA/EDD, should change
-in third trimester, shouldn’t change EDD
distinguishing missed abortion from inevitable abortion
-dilated os
Threatened abortion
- bleeding before 20 wks gestation.
- catch all
management inevitable abortion (fetal demise with os dilation)
- expectant
- D&C (heavy bleeding, pt preference)
- misoprostol (3-4 days, as opposed to 2-6 wks with expectant)
primary dysmenorrhea
- depression/anxiety
- tobacco use
- increase parity is negative RF
- most common in women in teens and twenties. associated with ovulatory cysts
- non-sexually active woman <20 w suprapubic pain in first two days of menses, can use NSAIDs w/o a pelvic exam
nabothen cysts on cervix
- inclusion cysts from metaplasia
- normal
Adenomyosis
- Abnormal glandular tissue w/i muscle
- often presents with menorrhagia. Uterus typically enlarged and diffusely boggy. Urinary/GI Sx
- Dx: U/S
- Tx: conservative, NSAIDs
Chronic PPID
-Lower abd pain, usually unrelated ot menses. Menorrhagia in 1/3 of women
Endometriosis Sx
Dyspareunia, bowel bladder symptoms that cycle with menses, fatigue, abnormal vaginal bleeding, effects on fertility. Chronic pelvic pain or dysmenorrhea.
Leiomyomas
- fibroids: benign tumors of the uterus. more common in Afr Am. Decreased risk with OCPs, parity, smoking. INcreased risk with early menarche, FHx fibroids, inc alcohol use.
- Sx: dysmenorrhea, urine/GI Sx, menorrhagia, anemia.
- Tx: NSAIDs, Mirena, OCPs, Depo-Provera, hysterectomy
Tx PMS/PMDD
- Danazol: androgen with progesterone effects. lowers estrogen and inhibits ovulation. androgenic SEs are undesirable.
- OCPs
- SSRIs. daily or luteal phase
primary vs secondary skin lesions
-secondary are changes that occur 2/2 progression of disease, scratching, or infection of primary lesions
macule vs patch
patch is > 1 cm
papule vs plaque
plaque is >1 cm
nodule
raise solid lesion
-epi, dermis, or subQ
tumor (derm)
solid mass of skin or subQ. larger than a nodule
vesicle vs bulla
bulla is > 1 cm